PTSD

>

Latest News

Doxazosin Shows Potential as Alternative PTSD-Related Nightmare Treatment
Doxazosin Shows Potential as Alternative PTSD-Related Nightmare Treatment

May 5th 2024

New literature review data suggests doxazosin is related to less incident hypotension than prazosin, while providing clinical benefit, in PTSD patients with condition-related nightmares.

PTSD Emotional Numbing Impacts Intensity of Neutral to Negative State Shifts
PTSD Emotional Numbing Impacts Intensity of Neutral to Negative State Shifts

April 16th 2024

MDMA-Assisted Therapy for PTSD Is Backed by Positive Data
MDMA-Assisted Therapy for PTSD Is Backed by Positive Data

April 4th 2024

Perinatal PTSD Diagnoses Rose 394 Percent From 2008 – 2020
Perinatal PTSD Diagnoses Rose 394 Percent From 2008 – 2020

April 3rd 2024

Psychiatry Month in Review: March 2024
Psychiatry Month in Review: March 2024

April 1st 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.